Chenjing Q. Wang
16 Jiangsu Road
Qingdao, 266003, China
Qingdao, 266003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Presence of drug-drug interactions between esomeprazole and an ALK tyrosine kinase inhibitor (Dirozalkib).
Journal: Cancer chemotherapy and pharmacology
Published: June 22, 2025
Safety, tolerability, pharmacokinetics, and pharmacodynamics of SHR-2010, a novel anti-MASP-2 antibody, in healthy volunteers: a randomized, double-blind, placebo-controlled phase 1 study.
Journal: Expert opinion on investigational drugs
Published: April 29, 2025
Pharmacokinetic and Bioequivalence Evaluation of Prolonged-Release Octreotide Acetate Microspheres in Healthy Human Subjects.
Journal: Clinical pharmacology in drug development
Published: November 29, 2024
HRS-5965, a small-molecule factor B inhibitor, in healthy participants and participants with renal insufficiency: A first-in-human, phase 1 trial.
Journal: Med (New York, N.Y.)
Published: November 13, 2024
Randomized, Double-Blind, Placebo-Controlled, Phase I, Dose- Escalation Study to Evaluate the Tolerance, Pharmacokinetics, Pharmacodynamics and Immunogenicity of PEGylated Urate Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers: Study Protocol.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: August 10, 2023
Tolerability, safety, and pharmacokinetics of a single intravenous administration of a novel recombinant humanized anti-interleukin-6 receptor monoclonal antibody in healthy Chinese volunteers.
Journal: Frontiers in pharmacology
Published: July 26, 2023
Jin-Zhen oral liquid for pediatric coronavirus disease (COVID-19): A randomly controlled, open-label, and non-inferiority trial at multiple clinical centers.
Journal: Frontiers in pharmacology
Published: November 10, 2022
Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects.
Journal: BMC pharmacology & toxicology
Published: June 30, 2022
Pharmacokinetics and safety of two Voriconazole formulations after intravenous infusion in two doses in healthy Chinese subjects.
Journal: BMC pharmacology & toxicology
Published: June 26, 2022
A Drug-Drug Interaction Study of a Novel Selective Urate Reabsorption Inhibitor, SHR4640, and Xanthine Oxidase Inhibitor, Febuxostat, in Patients With Primary Hyperuricemia.
Journal: Journal of clinical pharmacology
Published: June 25, 2022
The effect of rifampin on the pharmacokinetics of famitinib in healthy subjects.
Journal: Cancer chemotherapy and pharmacology
Published: June 21, 2022
Last Updated: 09/26/2026